Diabetes Mellitus Risk Prediction in the Framingham Offspring Study and Large Population Analysis
- PMID: 40218874
- PMCID: PMC11990307
- DOI: 10.3390/nu17071117
Diabetes Mellitus Risk Prediction in the Framingham Offspring Study and Large Population Analysis
Abstract
Background: Diabetes mellitus is a major cause of death and a significant risk factor for cardiovascular disease, kidney failure, neuropathy, and retinopathy. Our objectives were to develop a diabetes risk model and apply it to a large population. Methods: Non-diabetic adults in the Framingham Offspring Study (n = 2416) were followed for 10 years for new diabetes. At baseline, the fasting serum glucose, adiponectin, insulin, glycated albumin, total cholesterol, triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were measured using standardized automated assays. Standard health information was collected. Diabetes risk prediction models were developed using logistic regression analysis and applied to a large population (n = 133,764). Results: In this prospective study, 166 subjects (6.9%) developed new-onset diabetes. Glucose, body mass index (BMI), log adiponectin, % log glycated albumin, parental diabetes, TG, and the use of cholesterol-lowering medications entered the model (C statistic: 0.924; 0.898, biochemical variables: 0.898, and fasting glucose: only 0.876). In the population in non-diabetic subjects (56.3) and prediabetic subjects (36.2%), the predicted 10-year diabetes risk rates were 0.4% and 5.5% with the biochemical model, respectively. Prediabetic and diabetic subjects were insulin-resistant compared to non-diabetic subjects, but only those with diabetes had significant reductions in their insulin production. Conclusions: The 10-year risk of diabetes can be accurately predicted and applied to large populations. Fasting glucose alone is diagnostic for diabetes and is an excellent predictor of future diabetes, with having prediabetes increasing the risk 6-fold. Insulin and C-peptide measurements are useful in diabetic subjects to detect decreased insulin production and the need for insulin therapy.
Keywords: C-peptide; diabetes mellitus; glucose; insulin; risk prediction model; the Framingham Offspring Study.
Conflict of interest statement
There are no conflicts of interest, except that Margaret Diffenderfer is an employee of Boston Heart Diagnostics, Framingham, MA and Julia Maddalena was employed by the company Perennial Inc. This research was presented in part at the American Diabetes Association meetings in Orlando, FL, USA, 21 June 2024.
References
-
- Centers for Disease Control and Prevention Nathinal Diabetes Statistics Report. [(accessed on 12 January 2025)]; Available online: https://www.cdc.gov/diabetes/php/data-research.
-
- American Diabetes Association Professional Practice Committee 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47((Suppl. S1)):S158–S178. doi: 10.2337/dc24-S009. Erratum in Diabetes Care 2024, 47, 1238. https://doi.org/10.2337/dc24-er07a . - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
